Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginkgolide M is a naturally occurring diterpenoid lactone found in the leaves of the Ginkgo biloba tree. It belongs to the class of compounds known as ginkgolides, which are characterized by their unique cage-like structure and biological activity. Ginkgolides, including ginkgolide M, have been studied primarily for their ability to antagonize the platelet-activating factor receptor (PAFR), thereby inhibiting platelet aggregation and modulating inflammatory responses. While most research has focused on other members of this class (such as ginkgolide B), all ginkgolides share similar structural features and potential mechanisms of action. Ginkgo extracts containing these compounds have been investigated for neuroprotective effects, particularly in conditions like Alzheimer's disease and cerebrovascular disorders[3][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ginkgolide M.